Latest Acquisitions News

betr Entertainment Limited has increased its takeover offer for PointsBet shares to 4.375 betr shares per PointsBet share, valuing each at $1.40 and surpassing MIXI’s cash bid. The company also expanded its selective buy-back pool to $90 million, signaling confidence in its acquisition strategy.

Stealth Group Holdings has reported a record-breaking 2025 financial year, with sales climbing 27.6% and net profit more than doubling. The company is accelerating its growth strategy, aiming to more than double sales by 2028.

Stealth Group Holdings has reported a landmark FY25 with sales soaring 27.6% to $145.1 million and net profit more than doubling. The company’s strategic investments and operational discipline set the stage for ambitious growth targets through FY28.

Invictus Energy has forged a landmark partnership with Al Mansour Holdings, securing a strategic 19.9% stake and up to US$500 million in funding to advance its Cabora Bassa Project and expand into African upstream oil and gas markets.

archTIS Limited has reported FY25 results with solid ARR growth and completed a transformative acquisition of Spirion LLC, significantly boosting its US market presence and product suite. The company is raising $20.5 million to fund this expansion and accelerate growth.

archTIS Limited has acquired Spirion LLC’s technology, customers, and employees for A$15.7 million, significantly expanding its U.S. presence and product portfolio in data security. The deal adds A$17 million in annual recurring revenue and brings new cross-selling opportunities across a blue-chip customer base.

archTIS Limited reported a 38% revenue decline and an 11.8% rise in net loss for FY2025, yet achieved positive operating cash flow and secured $7.5 million in new capital to accelerate international expansion.

WAM Research Limited reported a robust 22.4% growth in its investment portfolio for FY2025, outperforming key ASX indices and declaring a 10 cents per share dividend, partially franked at 60%. The company’s disciplined focus on undervalued growth stocks underpinned strong returns despite market volatility.

NeuroScientific Biopharmaceuticals reports encouraging early clinical results for its StemSmart™ MSC therapy in preventing and treating kidney transplant rejection and injury.

Karoon Energy’s 2025 half-year results reveal a 4% rise in production alongside a significant drop in profits, driven by lower oil prices and increased costs. The company advances key projects and completes its Baúna FPSO acquisition, setting the stage for future growth.

Karoon Energy reported a 4% production increase in H1 2025 but saw underlying net profit after tax plunge 61%, driven by lower sales volumes and pricing. The company upgraded Baúna Project reserves by 35% and extended field life by seven years, while preparing for a CEO transition.

Karoon Energy reported a sharp 25% drop in revenue and a 61% plunge in net profit for H1 2025, but still declared a 5 cent interim dividend, signaling cautious confidence.